NAD
This article was originally published in The Rose Sheet
Executive Summary
The National Advertising Division of the Council of Better Business Bureaus has referred Freeman Beauty Labs to the Federal Trade Commission after the company failed to respond to the watchdog group's inquiry regarding claims for its Renewance Anti-Aging Chemical Peel, NAD reports Aug. 31. The group had requested substantiation for claims the product "offers a Pomegranate AntiOx Peptide Complex [that] restores skin's water, plumping fine lines and wrinkles," "protects against water loss and dehydration," and "delivers 92% wrinkle reduction, 88% tighter, toned skin, 92% smoother younger looking skin and 88% more radiant skin"...
You may also be interested in...
Anti-Aging Formula’s Ad Claims Unsupported By Studies – NAD
Freeman Beauty Labs will discontinue unsupported advertising claims for Renewance Anti-Aging Chemical Peel following a review by the National Advertising Division of the Council of Better Business Bureaus, which was featured in a recent Case Reports
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.